— Know what they know.
Not Investment Advice

LNTH NASDAQ

Lantheus Holdings, Inc.
1W: -2.3% 1M: +14.0% 3M: +27.9% YTD: +40.4% 1Y: +23.0% 3Y: -3.0% 5Y: +347.3%
$103.00
+8.53 (+9.03%)
 
Weekly Expected Move ±5.1%
$84 $89 $94 $99 $103
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Strong Buy · Power 70 · $6.7B mcap · 58M float · 1.71% daily turnover · Short 49% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$1.5B +0.5% ▲
5Y CAGR: +35.3%
Gross Profit
$942M -4.7% ▼
5Y CAGR: +46.7%
Operating Income
$311M -32.0% ▼
Net Income
$234M -25.2% ▼
EPS (Diluted)
$3.41 -21.8% ▼
EBITDA
$404M -21.7% ▼
5Y CAGR: +77.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$425M$935M$1.3B$1.5B$1.5B
YoY Growth+25.3%+119.9%+38.6%+18.3%+0.5%
Cost of Revenue$238M$353M$587M$546M$600M
Gross Profit$188M$582M$710M$988M$942M
Gross Margin44.1%62.2%54.7%64.4%61.1%
R&D Expenses$45M$312M$78M$168M$177M
SG&A Expenses$219M$234M$267M$372M$454M
Operating Expenses$249M$546M$345M$531M$631M
Operating Income-$61M$36M$365M$457M$311M
Operating Margin-14.3%3.9%28.1%29.8%20.2%
Interest Expense$8M$7M$20M$20M$20M
Income Before Tax-$75M$27M$411M$431M$314M
Tax Expense-$4M-$1M$84M$119M$80M
Net Income-$71M$28M$327M$312M$234M
Net Margin-16.8%3.0%25.2%20.4%15.2%
EPS (Diluted)$-1.06$0.40$4.65$4.36$3.41
EBITDA-$25M$82M$491M$515M$404M
Shares Outstanding67M71M70M72M68M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms